Tech Company Financing Transactions
TheraVida Funding Round
Private investors participated in a $8.9 million Series A funding round for TheraVida. The financing round was announced on 3/23/2012.
Transaction Overview
Company Name
Announced On
3/23/2012
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$8,904,894
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4819 Emperor Blvd. 400
Durham, NC 27517
USA
Durham, NC 27517
USA
Phone
Website
Email Address
Overview
Using a unique and patent-protected combination drug technology, TheraVida is able to develop urology pharmaceutical products that have significantly better side effect and safety profiles, when compared with predecessor therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benjamin McGraw
Browse more venture capital transactions:
Prev: 3/23/2012: Proteonomix venture capital transaction
Next: 3/23/2012: Nuage venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs